Health
Neuraptive Therapeutics Inc. Receives Orphan Drug Designation for its Lead Development Asset
Neuraptive Therapeutics Receives Orphan Drug Designation from the FDA for NTX-001 in Peripheral Nerve Injury Treatment
Wayne, PA – Neuraptive Therapeutics Inc., a pioneering biotechnology...
Health
NITI Aayog hosts workshop to enhance mental healthcare
Recognizing the intrinsic link between mental health and overall well-being, NITI Aayog recently conducted a workshop at the National Institute of Mental Health and...
Health
Ayurvedic Brahmastra Cure: Swamy Raj Vibhu’s Shadanga Pratistha/Kumbhak Chikitsa Revolutionizes Asthma Treatment
Business Wire India
Swamy Raj Vibhu, a pioneering figure in the world of holistic health, is rewriting the narrative of asthma treatment through his groundbreaking...
Health
P&G Health’s Nasivion Enters Asia Book of Records
Business Wire India
Nasivion, P&G Health’s trusted nasal decongestant, entered the prestigious ‘Asia Book of Records’ for creating the largest brand promotion sentence using snow....
Health
WomenLift Health Appoints Dr Ayesha Chaudhary as India Director
Business Wire India
WomenLift Health has appointed Dr Ayesha Chaudhary as India Director for its programs and strategic initiatives in the country. Ayesha, who has...
Health
WHO launches Traditional Medicine Morbidity codes comprising of 529 codes
The World Health Organisation on Wednesday launched the Traditional Medicine Morbidity codes of Ayurveda, Siddha and Unani Chapter in International Classification of Diseases (ICD)...
Health
WHO launches groundbreaking ICD-11 classification, integrating traditional medicine
The World Health Organization (WHO) is gearing up to introduce the 11th Edition of its International Classification of Diseases (ICD-11) in a groundbreaking move...
Health
Neuraptive Therapeutics, Inc. Announces Achievement of Proof of Concept in The NEUROFUSE Study of NTX-001 for the Adjunct Treatment of Transected Peripheral Nerves
Business Wire India
The NEUROFUSE Study is an ongoing 48-week Multicenter, Randomized, evaluator-blinded, Phase 2a study in upper extremity nerve transections comparing NTX-001 adjunctive...